Last reviewed · How we verify
NCT06843330
Accuracy of Lactate Meter in GSDIa
trial testing blood glucose meter; blood lactate meter in Glycogen Storage Disease Type Ia in 10 participants. Currently enrolling.
10 March 2027
Quick facts
| Lead sponsor | Connecticut Children's Medical Center |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 10 |
| Start date | 14 April 2025 |
| Primary completion | 10 March 2027 |
| Estimated completion | 10 December 2027 |
| Sites | 1 location across United States |
Drugs / interventions tested
- blood glucose meter; blood lactate meter
Conditions studied
- Glycogen Storage Disease Type Ia — all drugs for Glycogen Storage Disease Type Ia →
Sponsor
Connecticut Children's Medical Center
Who can join
Adults 0 to 60, any sex, with Glycogen Storage Disease Type Ia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this observational study is to determine if home lactate meters (both capillary and serum sample) are accurate, compared to lab serum lactate in a population of patients with glycogen storage disease type 1a and to determine if the Accu Chek Guide glucometer (capillary sample) is accurate, in a population of patients with glycogen storage disease type 1a.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06843330
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Glycogen Storage Disease Type Ia
Currently open trials in the same condition.
- NCT06735755 — A Phase 1/2, Dose-Exploration Study to Evaluate the Safety and Efficacy of BEAM-301 in Patients With Glycogen Storage Di · Phase 1, PHASE2 · recruiting
Other Connecticut Children's Medical Center trials
Trials by the same sponsor.
- NCT07224113 — Assessment and Educational Intervention to Reduce Ultra-processed Food Consumption in Pediatric Patients With IBD · recruiting
- NCT06982066 — Improving Communication Between AYA Oncology Patients and Clinicians: A Patient-Centered Intervention · NA · recruiting
- NCT06101264 — Application of Virtual Reality in Post-Operative Recovery of a Pediatric Scoliosis Patient Population · NA · completed
- NCT05874102 — The Effect of Body Position on Oropharyngeal Swallow Function in Infants · NA · completed
- NCT05792566 — ATOMIC Mobile App to Increase Physical Activity (PA) Levels in Survivors of Childhood Cancer · NA · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06843330 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Connecticut Children's Medical Center
- Last refreshed: 6 March 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06843330.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing